KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Intangibles (2016 - 2025)

Historic Intangibles for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $429.8 million.

  • Vertex Pharmaceuticals' Intangibles fell 4831.65% to $429.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.8 million, marking a year-over-year decrease of 4831.65%. This contributed to the annual value of $825.9 million for FY2024, which is 166.69% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Intangibles stood at $429.8 million, which was down 4831.65% from $435.5 million recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Intangibles peaked at $839.9 million during Q4 2023, and registered a low of $387.0 million during Q2 2022.
  • Moreover, its 5-year median value for Intangibles was $603.6 million (2022), whereas its average is $572.7 million.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Intangibles surged by 5596.9% in 2023 and then crashed by 4831.65% in 2025.
  • Vertex Pharmaceuticals' Intangibles (Quarter) stood at $400.0 million in 2021, then skyrocketed by 50.9% to $603.6 million in 2022, then soared by 39.15% to $839.9 million in 2023, then dropped by 1.67% to $825.9 million in 2024, then tumbled by 47.96% to $429.8 million in 2025.
  • Its last three reported values are $429.8 million in Q3 2025, $435.5 million for Q2 2025, and $441.2 million during Q1 2025.